ISPOR Europe 2021
ISPOR Europe 2021
Venez assister aux communications de congrĂšs de lâISPOR Europe 2021 pour dĂ©couvrir les 5 posters rĂ©alisĂ©s en collaboration avec CEMKA :
- Effectiveness of caplacizumab on reducing acute mortality in acquired thrombotic thrombocytopenic purpura: results from a french national registry (CNR-MAT)
- Cost-effectiveness of atezolizumab in association with bevacizumab for patients with untreated locally advanced or metastatic hepatocellular carcinoma (HCC) using a french real-world evidence database
- Prevalence of prurigo nodularis in the regional area of Brittany (France): estimation by matching two databases
- Health economic impact of phenylketonuria – A retrospective claims database study in France
- Cost-effectiveness analysis of neisvacÂź to prevent C-IMD in children and young people in France
   